Galapagos NV (Galapagos NV) FCF Yield % : -24.19 (As of Apr. 28, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Galapagos NV FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Galapagos NV's Trailing 12-Month Free Cash Flow is $-458.0 Mil, and Market Cap is $1,895.3 Mil. Therefore, Galapagos NV's FCF Yield % for today is -24.19%.

The historical rank and industry rank for Galapagos NV's FCF Yield % or its related term are showing as below:

GLPG' s FCF Yield % Range Over the Past 10 Years
Min: -26.68 Med: -3.95 Max: 46.23
Current: -24.19

During the past 13 years, the highest FCF Yield % of Galapagos NV was 46.23%. The lowest was -26.68%. And the median was -3.95%.

GLPG's FCF Yield % is ranked worse than
60.97% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs GLPG: -24.19

Galapagos NV's FCF Margin % for the quarter that ended in Dec. 2023 was 35.79%.

Galapagos NV FCF Yield % Historical Data

The historical data trend for Galapagos NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV FCF Yield % Chart

Galapagos NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

26.28

-9.75

-17.56

-19.49

-17.31

Galapagos NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-27.22	-16.68	-20.90	-22.88	-12.19

Competitive Comparison of Galapagos NV's FCF Yield %

For the Biotechnology subindustry, Galapagos NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galapagos NV's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Galapagos NV's FCF Yield % falls into.

Galapagos NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Galapagos NV's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-463.732	/	2678.717115
	=	-17.31%

Galapagos NV's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-81.618	*	4	/	2678.717115
	=	-12.19%

Galapagos NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Galapagos NV FCF Yield % Related Terms

Thank you for viewing the detailed overview of Galapagos NV's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV (Galapagos NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GLPG:Netherlands GLPG:Mexico 0JXZ:UK GXE:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.